COVID-19 Vaccine Challenges in Developing and Developed Countries

The coronavirus disease 2019 (COVID-19) pandemic has led to significant psychological and economical distress. Within a year after COVID-19 was declared a pandemic, several vaccines against COVID-19 were approved for emergency use. The journey from vaccine discovery to global herd immunity against C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarlagadda, Harshani, Patel, Meet A, Gupta, Vasu, Bansal, Toram, Upadhyay, Shubekshya, Shaheen, Nour, Jain, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085716/
https://www.ncbi.nlm.nih.gov/pubmed/35547442
http://dx.doi.org/10.7759/cureus.23951
_version_ 1784703879625048064
author Yarlagadda, Harshani
Patel, Meet A
Gupta, Vasu
Bansal, Toram
Upadhyay, Shubekshya
Shaheen, Nour
Jain, Rohit
author_facet Yarlagadda, Harshani
Patel, Meet A
Gupta, Vasu
Bansal, Toram
Upadhyay, Shubekshya
Shaheen, Nour
Jain, Rohit
author_sort Yarlagadda, Harshani
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic has led to significant psychological and economical distress. Within a year after COVID-19 was declared a pandemic, several vaccines against COVID-19 were approved for emergency use. The journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant challenges revolving around its development, affordability, accessibility, and acceptability at both a country level and an individual level. The main challenge faced by developed countries is the acceptability of the COVID-19 vaccine and the main challenge faced by developing countries is the affordability and accessibility of the COVID-19 vaccine.
format Online
Article
Text
id pubmed-9085716
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90857162022-05-10 COVID-19 Vaccine Challenges in Developing and Developed Countries Yarlagadda, Harshani Patel, Meet A Gupta, Vasu Bansal, Toram Upadhyay, Shubekshya Shaheen, Nour Jain, Rohit Cureus Family/General Practice The coronavirus disease 2019 (COVID-19) pandemic has led to significant psychological and economical distress. Within a year after COVID-19 was declared a pandemic, several vaccines against COVID-19 were approved for emergency use. The journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant challenges revolving around its development, affordability, accessibility, and acceptability at both a country level and an individual level. The main challenge faced by developed countries is the acceptability of the COVID-19 vaccine and the main challenge faced by developing countries is the affordability and accessibility of the COVID-19 vaccine. Cureus 2022-04-08 /pmc/articles/PMC9085716/ /pubmed/35547442 http://dx.doi.org/10.7759/cureus.23951 Text en Copyright © 2022, Yarlagadda et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Yarlagadda, Harshani
Patel, Meet A
Gupta, Vasu
Bansal, Toram
Upadhyay, Shubekshya
Shaheen, Nour
Jain, Rohit
COVID-19 Vaccine Challenges in Developing and Developed Countries
title COVID-19 Vaccine Challenges in Developing and Developed Countries
title_full COVID-19 Vaccine Challenges in Developing and Developed Countries
title_fullStr COVID-19 Vaccine Challenges in Developing and Developed Countries
title_full_unstemmed COVID-19 Vaccine Challenges in Developing and Developed Countries
title_short COVID-19 Vaccine Challenges in Developing and Developed Countries
title_sort covid-19 vaccine challenges in developing and developed countries
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085716/
https://www.ncbi.nlm.nih.gov/pubmed/35547442
http://dx.doi.org/10.7759/cureus.23951
work_keys_str_mv AT yarlagaddaharshani covid19vaccinechallengesindevelopinganddevelopedcountries
AT patelmeeta covid19vaccinechallengesindevelopinganddevelopedcountries
AT guptavasu covid19vaccinechallengesindevelopinganddevelopedcountries
AT bansaltoram covid19vaccinechallengesindevelopinganddevelopedcountries
AT upadhyayshubekshya covid19vaccinechallengesindevelopinganddevelopedcountries
AT shaheennour covid19vaccinechallengesindevelopinganddevelopedcountries
AT jainrohit covid19vaccinechallengesindevelopinganddevelopedcountries

Ejemplares similares